GraniteShares 1.5x Long Coinbase Daily ETF

Direxion Daily S&P Biotech Bull 3X ETF

iPath S&P 500 VIX ST Futures ETN

GraniteShares 1.5x Short NVDA Daily ETF

ARK Innovation ETF

Direxion Daily Small Cap Bull 3X ETF

ProShares UltraPro Dow30

ProShares UltraPro Short QQQ

ProShares UltraShort Silver

Health Care Select Sector SPDR ETF

Altimmune Inc. Common Stock

ProShares Ultra Semiconductors

GraniteShares 1.5x Long META Daily ETF

Direxion Daily S&P Biotech Bear 3X ETF

Mast Therapeutics, Inc.

GraniteShares 1.5x Long NVDA Daily ETF

Direxion Daily FTSE China Bull 3X ETF

GraniteShares 2x Long AMZN Daily ETF

Global X Uranium ETF

ProShares UltraPro QQQ

Siyata Mobile Inc. Common Shares

Capstone Holding Corp. Common Stock

Amesite Inc. Common Stock

Virgin Galactic Holdings Inc. Common Stock

Classover Holdings Inc. Class B Common Stock

Pasithea Therapeutics Corp. Common Stock

Gryphon Digital Mining Inc Common Stock

CoreWeave Inc. Class A Common Stock

Luminar Technologies Inc.  Class A Common Stock

Applied Digital Corporation Common Stock

Click Holdings Limited Ordinary Share

US Foods Holding Corp. Common Stock

Crown LNG Holdings Limited Ordinary Shares

Incannex Healthcare Limited American Depositary Shares

Aytu BioPharma Inc.  Common Stock

Nuvve Holding Corp. Common Stock

Asset Entities Inc. Class B Common Stock

Next Technology Holding Inc. Ordinary Shares

MicroAlgo Inc. Ordinary Shares

Hyperscale Data Inc. Common Stock

Click here to get full coverage on Major Shareholder Attacks Dynavax Management as Stock Hits 52-Week Low: Key Details from Scathing Letter - Stock Titan

Major Shareholder Attacks Dynavax Management as Stock Hits 52-Week Low: Key Details from Scathing Letter  Stock Titan

Major Shareholder Attacks Dynavax Management as Stock Hits 52-Week Low: Key Details from Scathing Letter - Stock Titan

Click here to get full coverage on Dynavax Files Preliminary Proxy Statement - PR Newswire

Dynavax Files Preliminary Proxy Statement  PR Newswire

Dynavax Files Preliminary Proxy Statement - PR Newswire

Click here to get full coverage on Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why - Yahoo Finance

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why  Yahoo Finance

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on DYNAVAX TECHNOLOGIES Earnings Results: $DVAX Reports Quarterly Earnings - Nasdaq

DYNAVAX TECHNOLOGIES Earnings Results: $DVAX Reports Quarterly Earnings  Nasdaq

DYNAVAX TECHNOLOGIES Earnings Results: $DVAX Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on (DVAX) Investment Report - news.stocktradersdaily.com

(DVAX) Investment Report  news.stocktradersdaily.com

(DVAX) Investment Report - news.stocktradersdaily.com

Click here to get full coverage on Dynavax Q1 Earnings: Vaccine Maker to Reveal Latest HEPLISAV-B Performance on May 6 - Stock Titan

Dynavax Q1 Earnings: Vaccine Maker to Reveal Latest HEPLISAV-B Performance on May 6  Stock Titan

Dynavax Q1 Earnings: Vaccine Maker to Reveal Latest HEPLISAV-B Performance on May 6 - Stock Titan

Click here to get full coverage on Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy - PR Newswire

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy  PR Newswire

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy - PR Newswire

Click here to get full coverage on Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Dynavax Defends $900M Growth Strategy Against Activist's Push for Quick Cash Return - Stock Titan

Dynavax Defends $900M Growth Strategy Against Activist's Push for Quick Cash Return  Stock Titan

Dynavax Defends $900M Growth Strategy Against Activist's Push for Quick Cash Return - Stock Titan

Click here to get full coverage on Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum - PR Newswire

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum  PR Newswire

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum - PR Newswire

Click here to get full coverage on Why Dynavax Technologies (DVAX) Stock Might be a Great Pick - Yahoo Finance

Why Dynavax Technologies (DVAX) Stock Might be a Great Pick  Yahoo Finance

Why Dynavax Technologies (DVAX) Stock Might be a Great Pick - Yahoo Finance

Click here to get full coverage on Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - Stock Titan

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value  Stock Titan

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - Stock Titan

Click here to get full coverage on Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs - PR Newswire

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs  PR Newswire

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs - PR Newswire

Click here to get full coverage on Dynavax Advances Board Refreshment Program - PR Newswire

Dynavax Advances Board Refreshment Program  PR Newswire

Dynavax Advances Board Refreshment Program - PR Newswire

Click here to get full coverage on Deep Track Capital Challenges Dynavax Board: 14.5% Stakeholder Demands Strategic Overhaul - Stock Titan

Deep Track Capital Challenges Dynavax Board: 14.5% Stakeholder Demands Strategic Overhaul  Stock Titan

Deep Track Capital Challenges Dynavax Board: 14.5% Stakeholder Demands Strategic Overhaul - Stock Titan

Click here to get full coverage on Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights - PR Newswire

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights  PR Newswire

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights - PR Newswire

Click here to get full coverage on Dynavax Shareholders Face Critical Vote as 267% Returns Challenge Activist Demands - Stock Titan

Dynavax Shareholders Face Critical Vote as 267% Returns Challenge Activist Demands  Stock Titan

Dynavax Shareholders Face Critical Vote as 267% Returns Challenge Activist Demands - Stock Titan

Click here to get full coverage on Dynavax Announces $100 Million Accelerated Share Repurchase Program - PR Newswire

Dynavax Announces $100 Million Accelerated Share Repurchase Program  PR Newswire

Dynavax Announces $100 Million Accelerated Share Repurchase Program - PR Newswire

Click here to get full coverage on Dynavax Fights $950M Revenue Giant's Board Control: 300% Returns at Stake - Stock Titan

Dynavax Fights $950M Revenue Giant's Board Control: 300% Returns at Stake  Stock Titan

Dynavax Fights $950M Revenue Giant's Board Control: 300% Returns at Stake - Stock Titan

Click here to get full coverage on 14% Shareholder Battles Dynavax Board: Settlement Rejected, Proxy Fight Looms - Stock Titan

14% Shareholder Battles Dynavax Board: Settlement Rejected, Proxy Fight Looms  Stock Titan

14% Shareholder Battles Dynavax Board: Settlement Rejected, Proxy Fight Looms - Stock Titan

Click here to get full coverage on Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest  Yahoo Finance

Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Click here to get full coverage on Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - Yahoo Finance

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value  Yahoo Finance

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - Yahoo Finance

Click here to get full coverage on Record Revenue vs Board Control: Inside Dynavax's $714M Battle with Deep Track Capital - Stock Titan

Record Revenue vs Board Control: Inside Dynavax's $714M Battle with Deep Track Capital  Stock Titan

Record Revenue vs Board Control: Inside Dynavax's $714M Battle with Deep Track Capital - Stock Titan

Click here to get full coverage on New Analyst Forecast: $DVAX Given $31.0 Price Target - Nasdaq

New Analyst Forecast: $DVAX Given $31.0 Price Target  Nasdaq

New Analyst Forecast: $DVAX Given $31.0 Price Target - Nasdaq

Click here to get full coverage on Dynavax Announces $200 Million Share Repurchase Program - PR Newswire

Dynavax Announces $200 Million Share Repurchase Program  PR Newswire

Dynavax Announces $200 Million Share Repurchase Program - PR Newswire

Click here to get full coverage on Can Dynavax's Upcoming Investor Presentations Reveal New Vaccine Development Strategy? - Stock Titan

Can Dynavax's Upcoming Investor Presentations Reveal New Vaccine Development Strategy?  Stock Titan

Can Dynavax's Upcoming Investor Presentations Reveal New Vaccine Development Strategy? - Stock Titan

Click here to get full coverage on We Think Dynavax Technologies' (NASDAQ:DVAX) Profit Is Only A Baseline For What They Can Achieve - simplywall.st

We Think Dynavax Technologies' (NASDAQ:DVAX) Profit Is Only A Baseline For What They Can Achieve  simplywall.st

We Think Dynavax Technologies' (NASDAQ:DVAX) Profit Is Only A Baseline For What They Can Achieve - simplywall.st

Click here to get full coverage on Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors - Business Wire

Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors  Business Wire

Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors - Business Wire

Click here to get full coverage on Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders - PR Newswire

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders  PR Newswire

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders - PR Newswire

Click here to get full coverage on Can Dynavax's New $225M Debt Deal Transform Its Financial Future? - Stock Titan

Can Dynavax's New $225M Debt Deal Transform Its Financial Future?  Stock Titan

Can Dynavax's New $225M Debt Deal Transform Its Financial Future? - Stock Titan

Click here to get full coverage on Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders - Business Wire

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders  Business Wire

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders - Business Wire

Click here to get full coverage on Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting - Business Wire

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting  Business Wire

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting - Business Wire

Click here to get full coverage on Dynavax Technologies (NASDAQ:DVAX) pulls back 3.7% this week, but still delivers shareholders massive 32% CAGR over 5 years - simplywall.st

Dynavax Technologies (NASDAQ:DVAX) pulls back 3.7% this week, but still delivers shareholders massive 32% CAGR over 5 years  simplywall.st

Dynavax Technologies (NASDAQ:DVAX) pulls back 3.7% this week, but still delivers shareholders massive 32% CAGR over 5 years - simplywall.st

Click here to get full coverage on Decoding Dynavax Technologies Corp (DVAX): A Strategic SWOT Insi - GuruFocus

Decoding Dynavax Technologies Corp (DVAX): A Strategic SWOT Insi  GuruFocus

Decoding Dynavax Technologies Corp (DVAX): A Strategic SWOT Insi - GuruFocus

Click here to get full coverage on Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share - Seeking Alpha

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share  Seeking Alpha

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share - Seeking Alpha

Click here to get full coverage on Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet - Nasdaq

Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet  Nasdaq

Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet - Nasdaq

Click here to get full coverage on Dynavax Technologies: Q1 Earnings Snapshot - CTPost

Dynavax Technologies: Q1 Earnings Snapshot  CTPost

Dynavax Technologies: Q1 Earnings Snapshot - CTPost

Click here to get full coverage on Dynavax Appoints New Chief Accounting Officer - TipRanks

Dynavax Appoints New Chief Accounting Officer  TipRanks

Dynavax Appoints New Chief Accounting Officer - TipRanks

Click here to get full coverage on SEC Form DEFA14A filed by Dynavax Technologies Corporation - Quantisnow

SEC Form DEFA14A filed by Dynavax Technologies Corporation  Quantisnow

SEC Form DEFA14A filed by Dynavax Technologies Corporation - Quantisnow

Click here to get full coverage on (DVAX) Investment Analysis and Advice - news.stocktradersdaily.com

(DVAX) Investment Analysis and Advice  news.stocktradersdaily.com

(DVAX) Investment Analysis and Advice - news.stocktradersdaily.com

Click here to get full coverage on DVAX stock touches 52-week high at $13.9 amid robust performance - Investing.com

DVAX stock touches 52-week high at $13.9 amid robust performance  Investing.com

DVAX stock touches 52-week high at $13.9 amid robust performance - Investing.com

Click here to get full coverage on Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits - Stock Titan

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits  Stock Titan

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits - Stock Titan

Click here to get full coverage on Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2025 Earnings Call Transcript - Insider Monkey

Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2025 Earnings Call Transcript  Insider Monkey

Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts - simplywall.st

Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts  simplywall.st

Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts - simplywall.st

Click here to get full coverage on Dynavax Technologies (DVAX) Maintains Market Outperform Rating | DVAX Stock News - GuruFocus

Dynavax Technologies (DVAX) Maintains Market Outperform Rating | DVAX Stock News  GuruFocus

Dynavax Technologies (DVAX) Maintains Market Outperform Rating | DVAX Stock News - GuruFocus

Click here to get full coverage on Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey

Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now?  Insider Monkey

Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey

Click here to get full coverage on Dynavax Technologies: Q1 Earnings Snapshot - MySA

Dynavax Technologies: Q1 Earnings Snapshot  MySA

Dynavax Technologies: Q1 Earnings Snapshot - MySA

Click here to get full coverage on Dynavax (DVAX) Price Target Reduced, Reports Strong HEPLISAV-B Sales Growth | DVAX Stock News - GuruFocus

Dynavax (DVAX) Price Target Reduced, Reports Strong HEPLISAV-B Sales Growth | DVAX Stock News  GuruFocus

Dynavax (DVAX) Price Target Reduced, Reports Strong HEPLISAV-B Sales Growth | DVAX Stock News - GuruFocus

Click here to get full coverage on Dynavax (DVAX) Urges Support for Board Nominees Ahead of 2025 Me - GuruFocus

Dynavax (DVAX) Urges Support for Board Nominees Ahead of 2025 Me  GuruFocus

Dynavax (DVAX) Urges Support for Board Nominees Ahead of 2025 Me - GuruFocus

Click here to get full coverage on Dynavax Technologies: Q1 Earnings Snapshot - San Antonio Express-News

Dynavax Technologies: Q1 Earnings Snapshot  San Antonio Express-News

Dynavax Technologies: Q1 Earnings Snapshot - San Antonio Express-News

Click here to get full coverage on Why Dynavax Technologies (DVAX) Stock Might be a Great Pick - TradingView

Why Dynavax Technologies (DVAX) Stock Might be a Great Pick  TradingView

Why Dynavax Technologies (DVAX) Stock Might be a Great Pick - TradingView

Click here to get full coverage on Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018 (DVAX) - Seeking Alpha

Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018 (DVAX)  Seeking Alpha

Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018 (DVAX) - Seeking Alpha

Click here to get full coverage on Earnings Flash (DVAX) Dynavax Technologies Posts Q1 Revenue $68.2M, vs. FactSet Est of $69.6M - marketscreener.com

Earnings Flash (DVAX) Dynavax Technologies Posts Q1 Revenue $68.2M, vs. FactSet Est of $69.6M  marketscreener.com

Earnings Flash (DVAX) Dynavax Technologies Posts Q1 Revenue $68.2M, vs. FactSet Est of $69.6M - marketscreener.com

Click here to get full coverage on Dynavax Technologies: What The Stock Buyback Means, What It Doesn't (NASDAQ:DVAX) - Seeking Alpha

Dynavax Technologies: What The Stock Buyback Means, What It Doesn't (NASDAQ:DVAX)  Seeking Alpha

Dynavax Technologies Corporation (DVAX)

Price Chart

Key Statistics

Technicals

About DVAX

Latest News

Major Shareholder Attacks Dynavax Management as Stock Hits 52-Week Low: Key Details from Scathing Letter - Stock Titan

Dynavax Files Preliminary Proxy Statement - PR Newswire

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers